Complex generics will boost speciality biz, Teva says By Dan Stanton+, 16-Jan-2014 Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business. http://www.in-pharmatechnologist.com/Drug-Delivery/Complex-generics-will-boost-speciality-biz-Teva-says
Prices soar for some generic drugs Victoria Colliver – Updated 12:13 pm, Wednesday, January 1, 2014 – www.sfgate.com The widespread use of generic medications is supposed to save the health care system money, but huge price spikes in certain common, previously low-cost drugs is putting some of that savings in question. Nosebleed-level price increases of more than […]
Plan Sponsors have done their best since 2006 to leave the independent, retail pharmacy out of Medicare Advantage and Standalone Part D preferred networks. The federal government (CMS), plan sponsors, PBMs & PSAOs are all responsible for this inequity. In fact, our federal legislators represented big money in enacting Part D laws and intentionally left […]
According to the most recent data, the Medicaid program pays for the prescription drugs of approximately 44 million Medicaid fee-for-service patients. By the second quarter of 2010, Medicaid had paid for more than 266 million prescriptions, with these prescription drug costs totaling about $20 billion dollars. Medicaid is expected to expand in 2014 as a […]
Trxade Health, Inc. (NASDAQ: MEDS)